The meeting brought together over 200 specialists from 25 countries, representing a truly international effort to advance research and clinical practice in the field of kidney diseases associated with monoclonal gammopathies.

The scientific programme featured a rich series of sessions addressing key areas in the field, including new pathophysiological insights into monoclonal gammopathies and kidney disease, innovations in diagnostic tools and biomarkers, emerging therapeutic strategies, and the latest updates from ongoing clinical trials.

It’s easy to read emotions on people’s faces — each one has its clear, unmistakable signature. But what about thoughts? A study published in Nature Neuroscience shows that mice’s problem-solving strategies can be deciphered from subtle facial movements. According to the authors, this is a proof of concept that the contents of the mind can be read out from video recordings, potentially offering powerful new research and diagnostic tools.   

The Cell Centre is looking to expand efforts in the GMP production of cell products with a specific focus on immune-monitoring. 

The successful applicant is expected to be pivotal co-worker in the development and improvement of immune cell-based therapies for malignant diseases and the preparation of GMP compliant production of cellular products including gene-modified immune cells and monitoring of anti-cancer directed vaccination.

Nicole explores how moving away from the “domino-chain” view of the brain toward seeing it as a complex dynamical system – full of feedback loops and interactions – is opening doors to exciting new discoveries. They talk about the challenges of measuring brain disorders, why fundamental research is so essential, and how predicting salmon populations can help predict seizures in the brain.

“The spinal cord isn’t just a passive relay station executing brain commands”, says Susana Lima, Principal Investigator of CF’s Neuroethology Lab and senior author of the study. “It integrates sensory inputs, responds to arousal, and adjusts its output based on the animal’s internal state. It’s much more sophisticated than we imagined”.

These three institutions stand out for their complementary and comprehensive work, which over decades has promoted eye health and reduced the burden of visual impairment, especially in the most disadvantaged regions of the world. 

With deep sorrow at the passing of Dr. Henrique Nabais, we pay tribute to our colleague and our friend. His unwavering dedication, leadership and professionalism earned him the highest regard and respect from all who knew him. We extend our heartfelt condolences to his family and friends.

Dr. Henrique Nabais led the Gynaecology Unit of the Champalimaud Clinical Centre since 2013. In these years, he left a profound and lasting mark on his colleagues, on the many patients he cared for, and on their families, whose trust he honoured with compassion and excellence.

An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.